Rop16-mediated activation of stat6 suppresses host cell reactive oxygen species production, facilitating type iii toxoplasma gondii growth and survival
Affiliation
Department of Immunobiology, University of ArizonaBIO5 Institute, University of Arizona
Department of Neurology, University of Arizona
Issue Date
2021
Metadata
Show full item recordPublisher
American Society for MicrobiologyCitation
Kochanowsky JA, Thomas KK, Koshy AA. 2021. ROP16-mediated activation of STAT6 suppresses host cell reactive oxygen species production, facilitating type III Toxoplasma gondii growth and survival. mBio 12:e03305-20.Journal
mBioRights
Copyright © 2021 Kochanowsky et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Polymorphic effector proteins determine the susceptibility of Toxoplasma gondii strains to IFN-γ-mediated clearance mechanisms deployed by murine host cells. However, less is known about the influence of these polymorphic effector proteins on IFN-γ-independent clearance mechanisms. Here, we show that deletion of one such polymorphic effector protein, ROP16, from a type III background leads to a defect in parasite growth and survival in unstimulated human fibroblasts and murine macrophages. Rescue of these defects requires a ROP16 with a functional kinase domain and the abil-ity to activate a specific family of host cell transcription factors (STAT3, 5a, and 6). The growth and survival defects correlate with an accumulation of host cell reactive oxygen species (ROS) and are prevented by treatment with an ROS inhibitor. Exogenous activation of STAT3 and 6 suppresses host cell ROS production during infection with ROP16-deficient parasites and depletion of STAT6, but not STAT3 or 5a, causes an accumulation of ROS in cells infected with wild-type parasites. Pharmacological inhibition of NOX2 and mitochondrially derived ROS also rescues growth and survival of ROP16-defi-cient parasites. Collectively, these findings reveal an IFN-γ-independent mechanism of parasite restriction in human cells that is subverted by injection of ROP16 by type III parasites. IMPORTANCE Toxoplasma gondii is an obligate intracellular parasite that infects up to one-third of the world’s population. Control of the parasite is largely accomplished by IFN-γ-dependent mechanisms that stimulate innate and adaptive immune responses. Parasite suppression of IFN-γ-stimulated responses has been linked to proteins that the parasite secretes into its host cell. These secreted proteins vary by T. gondii strain and determine strain-specific lethality in mice. How these strain-specific polymorphic effector proteins affect IFN-γ-independent parasite control mechanisms in human and murine cells is not well known. This study shows that one such secreted protein, ROP16, enables efficient parasite growth and survival by suppress-ing IFN-γ-independent production of ROS by human and mouse cells. Copyright © 2021 Kochanowsky et al.Note
Open access journalISSN
2161-2129Version
Final published versionae974a485f413a2113503eed53cd6c53
10.1128/mBio.03305-20
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright © 2021 Kochanowsky et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

